NAVIGATION

May 30, 2017
Prevacus

Photo:

Jacob VanLandingham

Profile

Prevacus

| 2/22/2013

Neuroscientist Jacob VanLandingham, an assistant professor at Florida State University's college of medicine, began research in 2004 to develop a drug to treat concussions. "We recognized within the last few years between military and sports injuries, that concussions have become an epidemic, so we made an effort to find something for this population." The result: VanLandingham recently patented a neurosteroid drug and launched a company, Prevacus, at Tallahassee’s Innovation Park, for work on funding, preclinical trials and product refinement. The development has sparked interest from the Department of Defense and from the University of Pittsburgh Medical Center, a professional sports affiliate that has agreed to help with clinical trials, which could begin within the next 18 to 36 months.

Tags: Trendsetters, Healthcare, Research & Development

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

R/V W.T. Hogarth Christening Ceremony
R/V W.T. Hogarth Christening Ceremony

With the crack of two bottles of champagne and the blessing from a local priest, Florida’s newest research vessel, the R/V W.T. Hogarth, was christened and launched for the first-time this week. The W.T. Hogarth will be used by the University of South Florida as well as more than two dozen institutions across the state.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Florida Memorial Day travel is expected to hit a 12 year high, are you traveling this weekend?

  • Yep!
  • Nope...

See Results

Ballot Box
Subscribe